Literature DB >> 11742855

Adaptation to lengthening contractions is independent of voluntary muscle recruitment but relies on inflammation.

Benoît M Lapointe1, Pierre Frémont, Claude H Côté.   

Abstract

Lengthening contractions trigger an adaptive response decreasing the susceptibility to exercise-induced muscle damage (EIMD). We hypothesized that 1) this adaptation can be observed when voluntary muscle recruitment is bypassed and 2) inflammation repression lessens the adaptive response. Rat ankle dorsiflexors were submitted to two bouts of elicited lengthening contractions 14 days apart; in vitro force production and macrophage concentrations were obtained before and 2 days after each bout in rats treated or not for 2 or 7 days with diclofenac. The first bout caused a 45% force deficit in the placebo group vs. 25% in the diclofenac group, whereas the ED1+ macrophage concentration increased by 10- and 5-fold, respectively. After the second bout, only diclofenac-treated rats (2 or 7 days) presented significant force deficits and increases in ED1+ and ED2+ macrophage concentrations, but this was more pronounced in the 7-day group. We conclude that adaptation to lengthening contractions does not depend on neural components but is likely mediated by strengthening of muscle structural/cellular elements and that inflammation is important for this process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11742855     DOI: 10.1152/ajpregu.00339.2001

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  18 in total

1.  Exercise, inflammation and aging.

Authors:  Jeffrey A Woods; Kenneth R Wilund; Stephen A Martin; Brandon M Kistler
Journal:  Aging Dis       Date:  2011-10-29       Impact factor: 6.745

Review 2.  Skeletal muscle damage with exercise and aging.

Authors:  Graeme L Close; Anna Kayani; Aphrodite Vasilaki; Anne McArdle
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 3.  Using recovery modalities between training sessions in elite athletes: does it help?

Authors:  Anthony Barnett
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

4.  Sequenced response of extracellular matrix deadhesion and fibrotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle.

Authors:  Abigail L Mackey; Simon Brandstetter; Peter Schjerling; Jens Bojsen-Moller; Klaus Qvortrup; Mette M Pedersen; Simon Doessing; Michael Kjaer; S Peter Magnusson; Henning Langberg
Journal:  FASEB J       Date:  2011-03-02       Impact factor: 5.191

5.  Cyclo-oxygenase-2 inhibitors : beneficial or detrimental for athletes with acute musculoskeletal injuries?

Authors:  Stuart J Warden
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

6.  Strategies Aimed at Preventing Chronic Post-surgical Pain: Comprehensive Perioperative Pain Management after Total Joint Replacement Surgery.

Authors:  Hance Clarke; Linda J Woodhouse; Deborah Kennedy; Paul Stratford; Joel Katz
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

7.  Resistance exercise and naproxen sodium: effects on a stable PGF2α metabolite and morphological adaptations of the upper body appendicular skeleton.

Authors:  Christi B Brewer; John P Bentley; Lainy B Day; Dwight E Waddell
Journal:  Inflammopharmacology       Date:  2015-08-20       Impact factor: 4.473

Review 8.  Recovery in soccer : part ii-recovery strategies.

Authors:  Mathieu Nédélec; Alan McCall; Chris Carling; Franck Legall; Serge Berthoin; Gregory Dupont
Journal:  Sports Med       Date:  2013-01       Impact factor: 11.136

Review 9.  Inflammation during skeletal muscle regeneration and tissue remodeling: application to exercise-induced muscle damage management.

Authors:  Bénédicte Chazaud
Journal:  Immunol Cell Biol       Date:  2015-11-03       Impact factor: 5.126

Review 10.  Use of nonsteroidal anti-inflammatory drugs following exercise-induced muscle injury.

Authors:  Angela Baldwin Lanier
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.